vs

Side-by-side financial comparison of Cellebrite DI Ltd. (CLBT) and Orion Group Holdings Inc (ORN). Click either name above to swap in a different company.

Cellebrite DI Ltd. is the larger business by last-quarter revenue ($292.2M vs $216.3M, roughly 1.4× Orion Group Holdings Inc). Orion Group Holdings Inc runs the higher net margin — 2.2% vs -103.5%, a 105.6% gap on every dollar of revenue. Over the past eight quarters, Cellebrite DI Ltd.'s revenue compounded faster (72.8% CAGR vs 6.1%).

Cellebrite DI Ltd. is a digital forensics company headquartered in Petah Tikva, Israel that provides tools for law enforcement agencies as well as enterprise companies and service providers to collect, review, analyze and manage digital data. Their flagship product series is the Cellebrite UFED.

Orion Corporation, founded in 1917 and headquartered at Espoo, Finland, is a globally operating Finnish company which develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients for global markets. All of the company's manufacturing sites and the majority of its R&D units are in Finland.

CLBT vs ORN — Head-to-Head

Bigger by revenue
CLBT
CLBT
1.4× larger
CLBT
$292.2M
$216.3M
ORN
Higher net margin
ORN
ORN
105.6% more per $
ORN
2.2%
-103.5%
CLBT
Faster 2-yr revenue CAGR
CLBT
CLBT
Annualised
CLBT
72.8%
6.1%
ORN

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
CLBT
CLBT
ORN
ORN
Revenue
$292.2M
$216.3M
Net Profit
$-302.3M
$4.7M
Gross Margin
84.6%
12.0%
Operating Margin
14.1%
Net Margin
-103.5%
2.2%
Revenue YoY
14.6%
Net Profit YoY
435.7%
EPS (diluted)
$-1.50
$0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLBT
CLBT
ORN
ORN
Q1 26
$216.3M
Q4 25
$233.2M
Q3 25
$292.2M
$225.1M
Q2 25
$220.8M
$205.3M
Q1 25
$89.6M
$188.7M
Q4 24
$216.9M
Q3 24
$232.1M
$226.7M
Q2 24
$185.3M
$192.2M
Net Profit
CLBT
CLBT
ORN
ORN
Q1 26
$4.7M
Q4 25
$-240.0K
Q3 25
$-302.3M
$3.3M
Q2 25
$36.9M
$841.0K
Q1 25
$-71.4M
$-1.4M
Q4 24
$6.8M
Q3 24
$4.3M
Q2 24
$-95.2M
$-6.6M
Gross Margin
CLBT
CLBT
ORN
ORN
Q1 26
12.0%
Q4 25
11.6%
Q3 25
84.6%
13.2%
Q2 25
84.1%
12.6%
Q1 25
85.2%
12.2%
Q4 24
14.0%
Q3 24
83.5%
11.9%
Q2 24
84.1%
9.5%
Operating Margin
CLBT
CLBT
ORN
ORN
Q1 26
Q4 25
2.2%
Q3 25
14.1%
2.4%
Q2 25
12.1%
1.7%
Q1 25
10.3%
0.4%
Q4 24
4.4%
Q3 24
7.9%
3.4%
Q2 24
11.7%
-1.4%
Net Margin
CLBT
CLBT
ORN
ORN
Q1 26
2.2%
Q4 25
-0.1%
Q3 25
-103.5%
1.5%
Q2 25
16.7%
0.4%
Q1 25
-79.7%
-0.7%
Q4 24
3.1%
Q3 24
1.9%
Q2 24
-51.4%
-3.4%
EPS (diluted)
CLBT
CLBT
ORN
ORN
Q1 26
$0.12
Q4 25
$-0.00
Q3 25
$-1.50
$0.08
Q2 25
$0.15
$0.02
Q1 25
$-0.36
$-0.04
Q4 24
$0.22
Q3 24
$-0.35
$0.12
Q2 24
$-0.48
$-0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLBT
CLBT
ORN
ORN
Cash + ST InvestmentsLiquidity on hand
$191.7M
$6.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$336.0M
$166.7M
Total Assets
$690.6M
$478.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLBT
CLBT
ORN
ORN
Q1 26
$6.3M
Q4 25
$1.6M
Q3 25
$191.7M
$4.9M
Q2 25
$326.1M
$1.7M
Q1 25
$191.7M
$13.0M
Q4 24
$28.3M
Q3 24
$189.5M
$28.3M
Q2 24
$178.6M
$4.8M
Total Debt
CLBT
CLBT
ORN
ORN
Q1 26
Q4 25
Q3 25
Q2 25
$33.4M
Q1 25
$23.3M
Q4 24
$23.2M
Q3 24
$28.0M
Q2 24
$60.3M
Stockholders' Equity
CLBT
CLBT
ORN
ORN
Q1 26
$166.7M
Q4 25
$159.0M
Q3 25
$336.0M
$157.9M
Q2 25
$408.4M
$153.2M
Q1 25
$336.0M
$150.8M
Q4 24
$150.7M
Q3 24
$34.2M
$142.4M
Q2 24
$-40.2M
$111.1M
Total Assets
CLBT
CLBT
ORN
ORN
Q1 26
$478.7M
Q4 25
$414.7M
Q3 25
$690.6M
$422.4M
Q2 25
$787.4M
$432.7M
Q1 25
$690.6M
$416.3M
Q4 24
$417.3M
Q3 24
$532.9M
$430.3M
Q2 24
$556.6M
$414.0M
Debt / Equity
CLBT
CLBT
ORN
ORN
Q1 26
Q4 25
Q3 25
Q2 25
0.22×
Q1 25
0.15×
Q4 24
0.15×
Q3 24
0.20×
Q2 24
0.54×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLBT
CLBT
ORN
ORN
Operating Cash FlowLast quarter
$66.2M
Free Cash FlowOCF − Capex
$60.8M
FCF MarginFCF / Revenue
20.8%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$172.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLBT
CLBT
ORN
ORN
Q1 26
Q4 25
$13.8M
Q3 25
$66.2M
$23.3M
Q2 25
$53.5M
$-5.6M
Q1 25
$10.0M
$-3.4M
Q4 24
$13.4M
Q3 24
$58.2M
$37.5M
Q2 24
$24.6M
$-15.3M
Free Cash Flow
CLBT
CLBT
ORN
ORN
Q1 26
Q4 25
$454.0K
Q3 25
$60.8M
$13.9M
Q2 25
$47.5M
$-12.7M
Q1 25
$8.5M
$-12.5M
Q4 24
$9.9M
Q3 24
$55.3M
$33.3M
Q2 24
$21.0M
$-20.0M
FCF Margin
CLBT
CLBT
ORN
ORN
Q1 26
Q4 25
0.2%
Q3 25
20.8%
6.2%
Q2 25
21.5%
-6.2%
Q1 25
9.5%
-6.6%
Q4 24
4.6%
Q3 24
23.8%
14.7%
Q2 24
11.3%
-10.4%
Capex Intensity
CLBT
CLBT
ORN
ORN
Q1 26
Q4 25
5.7%
Q3 25
1.8%
4.2%
Q2 25
2.7%
3.5%
Q1 25
1.7%
4.8%
Q4 24
1.6%
Q3 24
1.3%
1.8%
Q2 24
1.9%
2.4%
Cash Conversion
CLBT
CLBT
ORN
ORN
Q1 26
Q4 25
Q3 25
7.05×
Q2 25
1.45×
-6.61×
Q1 25
Q4 24
1.98×
Q3 24
8.79×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLBT
CLBT

Subscription services$197.2M67%
Term-license$60.8M21%
Professional services$23.2M8%
Other non-recurring$11.0M4%

ORN
ORN

Segment breakdown not available.

Related Comparisons